Acute stress is a physiological response of an organism to adverse conditions, contributing to survival; however, persistence through time may lead to disease. Indeed, exacerbation of inflammatory conditions such as psoriasis has been reported to follow stressors in susceptible patients. Because chronic stress cannot ethically be elicited in patients under controlled laboratory conditions, we studied genetically modified mice that naturally develop psoriasiform dermatitis, and subjected them to an ethological chronic social contact stress paradigm. Although we found elevated pro-inflammatory neuropeptide production of substance P (SP), calcitonin-gene-related peptide (CGRP) and nerve-growth factor (NGF) mRNA in the dorsal root ganglia (DRG) as well as pro-inflammatory cytokines in response to the social stressor, stress paradoxically prevented the development of the skin lesions. This effect of stress could be reversed by the treatment with glucocorticoid (GC) receptor blockers, suggesting that it was mediated through the upregulation of corticosterone secretion. Extrapolating to humans, the worsening of disease in susceptible patients with psoriasis could be attributed to a defect in the Hypothalamic-Pituitary-Adrenal (HPA) axis with an impaired production of GC during situations of adversity, thus rendering them unable to counteract the pro-inflammatory effects of chronic stressors.
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Introduction
Psoriasis, a chronic papulosquamous skin disease afflicting approximately 3% of the US population (Helmick et al., 2014 ) is associated with increased levels of distress, depression and anxiety (Rieder and Tausk, 2012) . Numerous investigators have found emotional stress an aggravating factor for psoriasis (Seville, 1977 (Seville, , 1978 Rieder and Tausk, 2012) , but precisely defining the role of stressors has proven complex, mostly because studies have been retrospective, based on patient recollection and thus subject to bias (Farber et al., 1986; Gaston et al., 1991; Farber and Nall, 1993) . Assessment of the effects of chronic stressors on disease progression becomes difficult in the absence of controlled laboratory studies, which ethically cannot be performed humans.
Psychological stress occurs when the environmental demands exceed the perception of the ability of a subject to cope with them (Cooper and Quick, 2017) . The term stress as originally coined by Selye (Selye, 1936) represented the organism's ability to adapt to acute perceived challenges with a stage of alarm (fight-flight) (Canon, 1939) Abbreviations: AD, atopic dermatitis; CGRP, calcitonin gene-related peptide; DRG, dorsal root ganglion; GR, glucocorticoid receptor resistance; HPA, hypothalamus-pituitary-adrenal; NGF, nerve growth factor; PACAP, pituitary adenylate cyclase-activating polypeptide; SP, substance P; TRPV1, transient receptor potential cation channel subfamily V member 1.
